AVE 0.00% 0.3¢ avecho biotechnology limited

Ann: First IND Enabling Study for TPM Oxymorphone Completed, page-33

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 513 Posts.
    Dear Goldenchook,

    I have to agree with your comments, its incredulous that a poster can deride the science using unnamed "execs" and then in the next breath ask for a Peer Review paper, seems contradictory or absurd.

    Can someone point out that a paper was published only 43 days ago?

    "Modulation of Phosphorylation of Tocopherol and Phosphatidylinositol by hTAP1/SEC14L2-Mediated Lipid Exchange"

    http://www.plosone.org/article/info:doi/10.1371/journal.pone.0101550#s3

    This study was supported in part by the Swiss National Science Foundation (AA, JMZ), by grants from US Department of Agriculture, under Agreement No. 58-1950-0-014 (MM, JMZ) and by a research fellowship from Phosphagenics, Ltd. (JMZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

    I don't expect non scientific people to understand it, however its a good paper.

    Over the last decade they had a Chair that was with the company for approximately 5 years, that chairperson had over 50 Scientific papers to his name at the time, to suggest that Professor Vizard would chair a company that didn't have valid credible science is extraordinary to say the least. It is a matter of public record that Professor Vizard made many statements that back the credibility of the body of work.

    During that time, if one looks they will find that Patents have been applied for in over 20 territories around the globe, you will not be granted a Patent if there is prior art.

    "Patent First, Publish Later: How Not to Ruin Your Chances of Winning a Patent"

    http://sciencecareers.sciencemag.or...articles/2001_10_26/nodoi.5362432760553307018

    " In Europe, for instance, there is no 1-year grace period--the chances of winning patent protection is lost the instant an invention becomes public. However, most European scientists are well aware of this "first to file" stipulation and file their patent applications before publishing or giving a presentation."

    "Patent Your Invention" UMKC ( University of Missouri-Kansas City )

    http://ors.umkc.edu/otc/process/publish-or-patent

    Honestly enough of this nonsense. Its as plain as the nose on my face why they didn't publish anything up until now. They would be throwing away company assets.

    BSW
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.3¢
Change
0.000(0.00%)
Mkt cap ! $7.923M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
35 43869108 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 44263580 22
View Market Depth
Last trade - 16.12pm 04/10/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.